Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028 and Upsize of Revolving Credit Facility

Group 1 - Integer Holdings Corporation has notified holders of its 2.125% Convertible Senior Notes due 2028 that the Notes are convertible from July 1, 2024, to September 30, 2024, at the option of the holders [1][3] - The conversion rate is set at 11.4681 shares of common stock per $1,000 principal amount of Notes, translating to a conversion price of approximately $87.20 per share [4] - The conversion became available as the last reported sale price of the Company's common stock exceeded 130% of the conversion price for at least 20 trading days within a 30-day period ending June 30, 2024 [3] Group 2 - The Company has amended its existing credit agreement to increase its maximum borrowing capacity under the revolving credit facility by $300 million, raising it from $500 million to $800 million [7] - The Chief Financial Officer stated that the Company aims to enhance its liquidity sources to support long-term strategic objectives while maintaining a debt leverage target of 2.5 to 3.5 [8] - Integer Holdings Corporation is a leading medical device contract development and manufacturing organization, serving various markets including cardiac rhythm management and neuromodulation [8]